High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes
Main Authors: | Hossein Sedighikamal, Alireza Sattarzadeh, Reza Karimi Mostofi, Behnoush Dinarvand, Madineh Nazarpour |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2023-10-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c03007 |
Similar Items
-
Infection kinetics of human adenovirus serotype 41 in HEK 293 cells
by: Joselma Siqueira-Silva, et al.
Published: (2009-08-01) -
CRISPR library screening to develop HEK293-derived cell lines with improved lentiviral vector titers
by: Brian J. Iaffaldano, et al.
Published: (2023-07-01) -
Huntington’s disease modeling on HEK293 cell line
by: D. V. Sharipova, et al.
Published: (2017-12-01) -
Microtubule Integrity Is Associated with the Functional Activity of Mitochondria in HEK293
by: Min Jeong Cho, et al.
Published: (2021-12-01) -
A New HEK293 Cell with CR2 Region of E1A Gene Deletion Prevents the Emergence of Replication-Competent Adenovirus
by: Xueqi Lian, et al.
Published: (2023-12-01)